A Study of BL-M07D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Low Expression Breast Cancer and Other Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Locally Advanced or Metastatic Solid Tumor
Interventions: DRUG: BL-M07D1
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Collaborators: SystImmune Inc.|Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.